(For treatment side effects and complications only)
Job Title: Consultant Haematologist
Qualifications: MB, ChB (Hons) MRCP FRCPath AFHEA
GMC Number: 6052663
Clinics: Royal Liverpool
Tumour site(s): Lymphoid malignancy
Dr Arumainathan did his undergraduate training at the University of Liverpool. The majority of his postgraduate training was in the Mersey region. His primary clinical focus is lymphoid malignancy (lymphoma/CLL), and he has a clinical interest in lymphoma in the setting of immune deficiency. He is the currently the lead for the CCC’s Lymphoma Site Reference Group.
He participates actively in clinical research and is the local principal investigator for several studies, and is also a clinical co-ordinator for national lymphoma/CLL trials run from the Liverpool Cancer Trials Unit. He has been the clinical lead for the integration of haemato-oncology into CCC since 2015.